These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4925535)

  • 1. Differential identification of Mycobacterium kansasii and Mycobacterium marinum.
    Silcox VA; David HL
    Appl Microbiol; 1971 Feb; 21(2):327-34. PubMed ID: 4925535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical mycobacteria isolated from diagnostic material.
    Hajós K; Juhász P
    Acta Microbiol Acad Sci Hung; 1970; 17(4):371-9. PubMed ID: 4998386
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification and differentiation of m. kansasii and m. marinum (m. balnei, m. platypoecilus).
    Juhlin I
    Bull Int Union Tuberc; 1967 Jun; 39(1):50-4. PubMed ID: 4863395
    [No Abstract]   [Full Text] [Related]  

  • 4. [Skin infections caused by Mycobacterium marinum: 5 cases].
    Song M; Demoulin L
    Acta Clin Belg; 1979; 34(4):214-9. PubMed ID: 525200
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mycobacterium kansasii and its variants].
    Schröder KH; Magnusson M
    Zentralbl Bakteriol Orig; 1968; 207(4):498-509. PubMed ID: 5742980
    [No Abstract]   [Full Text] [Related]  

  • 6. [Skin ulcer caused by Mycobacterium ulcerans in Cameroon. II. Bacteriological study].
    Boisvert H
    Bull Soc Pathol Exot Filiales; 1977; 70(2):125-31. PubMed ID: 579612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differentiation of slow-growing scotochromogenous mycobacteria].
    Schröder KH; Pfirrmann K; Töpfer M; Hoff K
    Zentralbl Bakteriol Orig; 1971; 216(2):228-38. PubMed ID: 5551866
    [No Abstract]   [Full Text] [Related]  

  • 8. [Some biological properties of clinically significant and apparently clinically non-significant strains of Mycobacterium kansasii].
    Pollak L; Angulo-Ortega A
    Pneumonologie; 1970; 142(2):102-7. PubMed ID: 5497295
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sulfadimethoxine as a promising drug in the treatment of infections caused by Mycobacterium kansasii and Mycobacterium xenopi--differentiation between M. kansasii and M. marinum and between M. gordonae and M. scrofulaceum by the susceptibility testing to sulfadimethoxine].
    Tsukamura M
    Kekkaku; 1989 Apr; 64(4):313-7. PubMed ID: 2747117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophage typing and chemical and biologic tests in the classification of mycobacteria. A comparative study.
    Mankiewicz E; Dernuet S
    Am Rev Respir Dis; 1968 Jul; 98(1):35-40. PubMed ID: 5657151
    [No Abstract]   [Full Text] [Related]  

  • 11. In-vitro susceptibility of mycobacteria to ciprofloxacin.
    Collins CH; Uttley AH
    J Antimicrob Chemother; 1985 Nov; 16(5):575-80. PubMed ID: 2934361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on slow growing chromogenic (Runyon's group II) mycobacteria].
    Pattyn SR; Hermans-Boveroulle MT; van Ermengem J
    Zentralbl Bakteriol Orig; 1968; 207(4):509-16. PubMed ID: 5742981
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of microscopic morphology in smears prepared from radiometric cultures for presumptive identification of Mycobacterium tuberculosis complex, Mycobacterium avium complex, Mycobacterium kansasii, and Mycobacterium xenopi.
    González J; Tudó G; Gómez J; Garciá A; Navarro M; Jiménez de Anta MT
    Eur J Clin Microbiol Infect Dis; 1998 Jul; 17(7):493-500. PubMed ID: 9764552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of three culture methods for the isolation of mycobacteria from clinical samples.
    Sorlozano A; Soria I; Roman J; Huertas P; Soto MJ; Piedrola G; Gutierrez J
    J Microbiol Biotechnol; 2009 Oct; 19(10):1259-64. PubMed ID: 19884789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance and differentiation of atypical mycobacteria].
    Naumann W
    Arch Hyg Bakteriol; 1967 Aug; 151(3):332-59. PubMed ID: 4882423
    [No Abstract]   [Full Text] [Related]  

  • 16. Differentiation between Mycobacterium kansasii and Mycobacterium marinum by gas-liquid chromatographic analysis of cellular fatty acids.
    Thoen CO; Karlson AG; Ellefson RD
    Appl Microbiol; 1972 Dec; 24(6):1009-10. PubMed ID: 4650594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation between Mycobacterium kansasii and M. gastri.
    Tsukamura M
    J Gen Microbiol; 1973 Jan; 74(1):193-4. PubMed ID: 4695046
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostic key to mycobacteria encountered in clinical laboratories.
    Wayne LG; Doubek JR
    Appl Microbiol; 1968 Jun; 16(6):925-31. PubMed ID: 4874455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium marinum infections in man.
    Collins CH; Grange JM; Noble WC; Yates MD
    J Hyg (Lond); 1985 Apr; 94(2):135-49. PubMed ID: 3886781
    [No Abstract]   [Full Text] [Related]  

  • 20. Gas chromatographic assay of cellular fatty acids and alcohols for the identification of Mycobacterium species.
    Pinsi G; Signorini C; Gelmi M; Garrafa E; Albertini A; Turano A
    New Microbiol; 1999 Apr; 22(2):151-4. PubMed ID: 10322614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.